Warthin's tumor surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mahshid |
||
Line 16: | Line 16: | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Otolaryngology]] | |||
[[Category:Gastroenterology]] |
Revision as of 17:45, 27 November 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Warthin's tumor Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Warthin's tumor surgery On the Web |
American Roentgen Ray Society Images of Warthin's tumor surgery |
Risk calculators and risk factors for Warthin's tumor surgery |
Overview
Surgery is the mainstay of treatment for Warthin's tumor.
Surgery
- Surgery is the mainstay of treatment for Warthin's tumor. Recurrence is rare, occurring in 6 - 12% of cases. Warthin's tumor is highly unlikely to become malignant.
- Surgery should be followed by careful observation to watch for changes in the tumor over time.[1] Frey syndrome has been successfully treated with injections of botulinum toxin A.[2]
References
- ↑ Gooden E, Witterick IJ, Hacker D, Rosen IB, Freeman JL (2002). "Parotid gland tumours in 255 consecutive patients: Mount Sinai Hospital's quality assurance review". J Otolaryngol. 31 (6): 351–4. PMID 12593546.
- ↑ Salivary gland tumor. Cancer.gov (2016). http://www.cancer.gov/types/head-and-neck/hp/salivary-gland-treatment-pdq Accessed on January 4, 2016